Hsa_circ_0003258 drives serine biosynthesis and docetaxel resistance in prostate cancer by enhancing IGF2BP3-mediated PSAT1 mRNA stability
Drug Resistance Updates · 2026-09 · 88 · 101438
DOI: 10.1016/j.drup.2026.101438 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Resistance Updates, 2026-09. Verfasst von Shengdong Ge und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Fifth Affiliated Hospital, Southern Medical University, Guangzhou, Guangdong 510900, China; Department of Urology, Nanfang…. Hauptthemen laut MEDLINE: Docetaxel, Drug Resistance, Neoplasm, Prostatic Neoplasms, RNA-Binding Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Docetaxel (DTX)-based therapy remains first-line treatment for advanced prostate cancer (PCa), yet its efficacy is often compromised by chemoresistance. Emerging evidence highlights that circular RNAs (circRNAs) contribute to the development of chemoresistance, but their specific functions in DTX-resistant PCa remain poorly understood. METHODS: By integrating molecular biology, cell biology, and immunology approaches, we investigated the mechanism by which hsa_circ_0003258 drives DTX resistance in PCa. RESULTS: We identified that hsa_circ_0003258 was significantly elevated in DTX-resistant patients of PCa. Functional experiments confirmed that hsa_circ_0003258 enhances DTX resistance both in vitro and in vivo by promoting cancer stem-like properties, independent of its linear transcript. Mechanistically, hsa_circ_0003258 directly bound the RRMs and KH1 domains of IGF2BP3 via its CAUU motif, augmenting the non-competitive interaction between IGF2BP3's KH4 domain and the 3'UTR of PSAT1 mRNA. This led to increased PSAT1 mRNA stability and activation of the serine biosynthesis, thereby reinforcing stemness and driving DTX resistance of PCa. To explore therapeutic potential, we engineered targeted nanoliposomes (HA-LNP@si-hsa_circ_0003258/cy7) which selectively accumulated in PCa xenografts and significantly inhibited tumor growth in combination with DTX. Co-treatment with Bix, a G9a inhibitor previously reported to suppress PSAT1 expression, further enhanced the antitumor efficacy of this combination, suggesting a potential synergistic therapeutic effect. CONCLUSION: Our findings reveal a novel hsa_circ_0003258/IGF2BP3/PSAT1 axis that enhances de novo serine synthesis and drives DTX resistance in PCa, highlighting this pathway as a promising therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The Fifth Affiliated Hospital, Southern Medical University, Guangzhou, Guangdong 510900, China; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, C…
- Department of Urology, The Fifth Affiliated Hospital, Southern Medical University, Guangzhou, Guangdong 510900, China.
- Center of Rehabilitation Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong 510282, China.
- Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China.
- Department of Urology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, China.
- The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, China.
Förderung
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Ge, S., Liu, X., Zeng, X., Tang, Y., Yu, Y., Li, H., Chen, H., Li, X., Cen, J., He, J., Xie, Z., Shi, J., Feng, N. H., Song, X. L., & Zhao, S. C. (2026). Hsa_circ_0003258 drives serine biosynthesis and docetaxel resistance in prostate cancer by enhancing IGF2BP3-mediated PSAT1 mRNA stability. Drug Resistance Updates, 88, 101438. https://doi.org/10.1016/j.drup.2026.101438
Vancouver
Ge S, Liu X, Zeng X, Tang Y, Yu Y, Li H, et al. Hsa_circ_0003258 drives serine biosynthesis and docetaxel resistance in prostate cancer by enhancing IGF2BP3-mediated PSAT1 mRNA stability. Drug Resistance Updates. 2026;88:101438. doi:10.1016/j.drup.2026.101438
BibTeX
@article{Ge2026,
author = {Ge, Shengdong and Liu, Xiaofeng and Zeng, Xianzi and Tang, Yuting and Yu, Yuzhong and Li, Haolin and Chen, Hongda and Li, Xingjian and Cen, Jinpeng and He, Jiaze and Xie, Zhiyue and Shi, Jiarui and Feng, Ning-Han and Song, Xian-Lu and Zhao, Shan-Chao},
title = {Hsa_circ_0003258 drives serine biosynthesis and docetaxel resistance in prostate cancer by enhancing IGF2BP3-mediated PSAT1 mRNA stability},
journal = {Drug Resistance Updates},
year = {2026},
volume = {88},
pages = {101438},
doi = {10.1016/j.drup.2026.101438}
}
EUVIMED